Introduction
Cutisone Ointment 0.005% is a synthetic corticosteroid used for its anti-inflammatory and immunosuppressive effects. It is commonly used in treating various allergic and inflammatory conditions such as asthma and rhinitis. Available in various formulations including inhalers, nasal sprays, and topical creams, Cutisone Ointment 0.005% is effective in reducing inflammation and managing symptoms related to these conditions.
Uses
Cutisone Ointment 0.005% is used for:
- Asthma: As an inhaled corticosteroid, it helps in preventing and controlling asthma symptoms by reducing inflammation in the airways.
- Allergic Rhinitis: As a nasal spray, it alleviates symptoms such as nasal congestion, sneezing, and runny nose caused by allergic rhinitis.
- Dermatologic Conditions: In topical form, it is used for treating various inflammatory skin conditions such as eczema and dermatitis.
| Brand Name | Cutisone |
|---|---|
| Type | Ointment |
| Weight | 0.005% |
| Generic | Fluticasone Propionate |
| Manufacturer | General Pharmaceuticals Ltd. |
| Available in | English বাংলা |
Mechanism of Action
Cutisone Ointment 0.005% exerts its effects by binding to corticosteroid receptors in cells, leading to the suppression of inflammatory mediators such as cytokines and prostaglandins. This reduces inflammation and immune response in affected tissues. In the airways, it decreases the number of inflammatory cells, thereby reducing swelling and mucus production.
How Long Does It Take to Work?
The onset of action varies depending on the formulation:
- Inhaled Form: Improvement in asthma symptoms may be observed within a few days, but full benefits can take several weeks of consistent use.
- Nasal Spray: Relief from allergic rhinitis symptoms may be noticeable within 1-2 days, with maximum benefit achieved in about 1-2 weeks.
- Topical Form: Improvement in skin conditions typically occurs within a few days to weeks, depending on the severity of the condition.
Absorption
Cutisone Ointment 0.005% has low systemic absorption when used as an inhaler or nasal spray. For the inhaled formulation, only a small fraction of the dose reaches the systemic circulation. In topical applications, the absorption is minimal, with local effects predominant. The low systemic absorption minimizes the risk of systemic side effects.
Route of Elimination
Cutisone Ointment 0.005% is primarily metabolized in the liver by cytochrome P450 enzymes. It is then excreted in the urine as metabolites. Minimal systemic absorption from topical and inhaled formulations contributes to a reduced risk of systemic elimination issues.
Dosage
The dosage of Cutisone Ointment 0.005% varies based on the condition and formulation:
- Asthma: Typically, 100-500 mcg twice daily using an inhaler. The dose may be adjusted based on the severity of symptoms and response.
- Allergic Rhinitis: Generally, 1-2 sprays per nostril once daily. Adjustments may be made based on symptom control.
- Dermatologic Conditions: Apply a thin layer to the affected area 1-2 times daily, depending on the severity and response.
Administration
Administration depends on the formulation:
- Inhaler: Inhale the prescribed dose through the mouth using a metered-dose inhaler or dry powder inhaler.
- Nasal Spray: Administer into each nostril as directed, ensuring proper technique for effective delivery.
- Topical Cream/Ointment: Apply evenly to the affected skin areas, avoiding contact with sensitive areas such as the eyes.
Side Effects
Common side effects may include:
- Inhaled Form: Oral thrush, hoarseness, coughing.
- Nasal Spray: Nasal irritation, bleeding, or dryness.
- Topical Form: Skin irritation, thinning, or redness.
Toxicity
Toxicity is rare with appropriate use. Excessive use, especially of topical forms, can lead to systemic corticosteroid effects such as adrenal suppression. Inhaled or nasal overdose can lead to symptoms such as oral thrush or systemic corticosteroid effects. Immediate medical attention should be sought in case of suspected overdose.
Precautions
Precautions include:
- Monitor for signs of oral thrush with inhaled forms and consider using a spacer or rinsing the mouth after use.
- For nasal formulations, avoid use in the presence of nasal infections or untreated infections.
- Topical use should be limited to recommended areas and durations to prevent adverse effects.
Interaction
Interactions are minimal with topical and inhaled forms. However, with systemic use or if used with other corticosteroids, interactions can occur. Always inform a healthcare provider of all medications and treatments being used to avoid potential interactions.
Disease Interaction
Use with caution in:
- Patients with active infections, tuberculosis, or conditions that may be exacerbated by corticosteroids.
- Individuals with a history of adrenal insufficiency or other systemic effects related to corticosteroid use.
Drug Interaction
Potential interactions include:
- Other Corticosteroids: Concurrent use with other systemic corticosteroids may increase the risk of systemic effects.
- CYP3A4 Inhibitors: Drugs that inhibit CYP3A4 may increase the plasma levels of Cutisone Ointment 0.005% and enhance its effects.
Food Interactions
There are no significant food interactions with Cutisone Ointment 0.005%. The medication is absorbed systemically in minimal amounts, and its effectiveness is not significantly affected by food intake.
Pregnancy Use
Cutisone Ointment 0.005% should be used during pregnancy only if clearly needed. Animal studies have shown no harm, but adequate human studies are lacking. The benefits should be weighed against potential risks, and a healthcare provider should be consulted for personalized advice.
Lactation Use
Cutisone Ointment 0.005% can be used during lactation, but it is essential to use the medication according to prescribed guidelines to minimize exposure to the infant. Consult a healthcare provider for guidance on using the medication while breastfeeding.
Acute Overdose
Acute overdose is rare but can lead to symptoms such as adrenal suppression or systemic corticosteroid effects. If an overdose is suspected, seek immediate medical attention. Management focuses on symptomatic relief and supportive care.
Contraindication
Cutisone Ointment 0.005% is contraindicated in:
- Individuals with hypersensitivity to Cutisone Ointment 0.005% or any component of the formulation.
- Patients with untreated infections, especially fungal, bacterial, or viral infections, due to the risk of exacerbation.
Use Direction
Follow the prescribed directions for application or inhalation. For inhaled forms, ensure proper technique and adherence to the dosage schedule. For nasal sprays and topical forms, apply as directed to avoid overuse and maximize efficacy.
Storage Conditions
Store Cutisone Ointment 0.005% at room temperature, away from direct sunlight and moisture. Keep out of reach of children to prevent accidental ingestion or misuse. Proper storage ensures the medication's effectiveness and safety.
Volume of Distribution
The volume of distribution for Cutisone Ointment 0.005% is not well-defined due to its minimal systemic absorption from topical and inhaled formulations. The primary action is localized to the site of application or inhalation.
Half Life
The half-life of Cutisone Ointment 0.005% varies based on the formulation:
- Inhaled Form: Approximately 8 hours in the systemic circulation, though the primary effects are localized.
- Topical Form: The systemic half-life is minimal due to limited absorption.
Clearance
Cutisone Ointment 0.005% is primarily cleared through hepatic metabolism and subsequent urinary excretion. The minimal systemic absorption from topical and inhaled forms contributes to a reduced systemic clearance rate and limited risk of systemic effects.
See in details version Cutisone Ointment 0.005% also Cutisone Ointment 0.005% in bangla
Social card
